Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 5/2017

01-09-2017 | Images in Metabolic Medicine

Carnitine palmitoyltransferase 1A deficiency: abnormal muscle biopsy findings in a child presenting with Reye’s syndrome

Authors: M. Bellusci, P. Quijada-Fraile, D. Barrio-Carreras, E. Martin-Hernandez, M. Garcia-Silva, B. Merinero, B. Perez, A. Hernandez-Lain

Published in: Journal of Inherited Metabolic Disease | Issue 5/2017

Login to get access

Excerpt

A 4-year-old girl was admitted to pediatric intensive care unit due to Reye’s syndrome. Her medical history was notable for recurrent episodes of hypoglycemia when ill. Plasma levels of acylcarnitines and free carnitine (C0) were not remarkable, but creatine kinase (CK) level was increased (1674 U/l). A muscle biopsy was performed that showed severe and diffuse accumulation of lipid in muscle fibers (Fig. 1). Acylcarnitine profile was reviewed. Liver isoform of carnitine palmitoyltransferase IA (CPTIA) deficiency was suspected because of the increased C0/ [palmitoylcarnitine (C16) + stearoylcarnitine (C18)] ratio: 2190 (normal value 266–1510). With dietary treatment, rapid and dramatic improvement was observed. Two novel variants in the CPT1A gene were found: c.627delT (severe mutation) and c.1006G > A (predicted as damaging by several bioinformatic algorithms).
Literature
go back to reference Britton CH, Mackey DW, Esser V et al (1997) Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A and CPT1B). Genomics 40:209–211CrossRefPubMed Britton CH, Mackey DW, Esser V et al (1997) Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I (CPT1A and CPT1B). Genomics 40:209–211CrossRefPubMed
go back to reference Fingerhut R, Röschinger W, Muntau AC et al (2001) Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin Chem 47:1763–1768PubMed Fingerhut R, Röschinger W, Muntau AC et al (2001) Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin Chem 47:1763–1768PubMed
go back to reference Haworth J, Demaugre F, Booth F et al (1992) Atypical features of the hepatic form of carnitine palmitoyl- transferase deficiency in a Hutterite family. J Pediatr 121:553–557CrossRefPubMed Haworth J, Demaugre F, Booth F et al (1992) Atypical features of the hepatic form of carnitine palmitoyl- transferase deficiency in a Hutterite family. J Pediatr 121:553–557CrossRefPubMed
go back to reference Lee BH, Kim YM, Kim JH et al (2015) Atypical manifestation of carnitine palmitoyltransferase 1A deficiency: hepatosplenomegaly and nephromegaly. J Pediatr Gastroenterol Nutr 60:e19–e22CrossRefPubMed Lee BH, Kim YM, Kim JH et al (2015) Atypical manifestation of carnitine palmitoyltransferase 1A deficiency: hepatosplenomegaly and nephromegaly. J Pediatr Gastroenterol Nutr 60:e19–e22CrossRefPubMed
go back to reference Olpin SE, Allen J, Bonham JR et al (2001) Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis 24:35–42CrossRefPubMed Olpin SE, Allen J, Bonham JR et al (2001) Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis 24:35–42CrossRefPubMed
Metadata
Title
Carnitine palmitoyltransferase 1A deficiency: abnormal muscle biopsy findings in a child presenting with Reye’s syndrome
Authors
M. Bellusci
P. Quijada-Fraile
D. Barrio-Carreras
E. Martin-Hernandez
M. Garcia-Silva
B. Merinero
B. Perez
A. Hernandez-Lain
Publication date
01-09-2017
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 5/2017
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0041-7

Other articles of this Issue 5/2017

Journal of Inherited Metabolic Disease 5/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.